BRCA2 and uterine carcinosarcoma: Only two patients tested were found to have a mutation in a BRCA gene (20%), and one of these was a patient with uterine carcinosarcoma, who was found to have a variant of unknown significance in the BRCA2 gene, for a final pathogenic mutation rate of 10%.